• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec10
Canaccord Genuity Analyst Maintains Buy Rating on TransMedics Group
12:07
Dec5
TransMedics Director David Weill Disposes of Company Common Stock
21:30
Dec3
William Blair Analyst Maintains Buy Rating on TransMedics Group
19:12
Nov27
TransMedics Executives Sell $435,660 in Stock
03:32
Nov26
TransMedics Group Inc. Official Disposes of Common Stock
21:31
Nov18
TransMedics CEO and President Acquires Common Stock
21:30

Schedules & Filings

Schedules
Filings
Oct29
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 143.82 M, Net Income 24.32 M, EPS 0.6601

Jul30
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 157.37 M, Net Income 34.91 M, EPS 0.9186

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 143.54 M, Net Income 25.68 M, EPS 0.7021

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More